您要查找的是不是：
- Median overall survival of all 211 patients was 49.3 months. 所有211名患者的中位总存活数是49.;3个月。
- MabThera has revolutionized the treatment of lymphoma and is the first therapy in over 20 years to increase overall survival for aggressive non-Hodgkin's Lymphoma patients. 美罗华 实现了淋巴瘤治疗方面的革命，是20多年来的首个能提高侵袭性非霍奇金氏淋巴瘤患者的总存活率的药物。
- Median TTF was 5.5 months, and median overall survival (OS) was 22.4 months. 中位治疗失败时间为5.;5个月，中位生存期22
- BMI and visceral adiposity showed no influence on overall survival of patients. BMI及内脏肥胖对总生存没有影响。
- Dr Smith concludes: "Our results indicate that trastuzumab [Herceptin] shows a significant overall survival benefit in early breast cancer over observation alone after chemotherapy. 研究结果表明与单纯化疗后观察比较，应用群司珠单抗[赫赛汀]可使早期乳腺癌患者总生存率明显提高。
- The five-gene signature was an independent predictor of relapse-free and overall survival. 这五个基因是对无复发和总生存率的独立预测指标。
- The 3-year overall survival (OS) and disease free survival ( DFS) was 66. 3% and 59. 5% , respectively. 3年总生存率和无病生存率分别为66.;3%25和59
- The 5 -year overall survival (OS) and disease free survival (DFS) were 89% and 73%,respectively. 全组5年总生存率和无病生存率分别为89%25和73%25。
- Our five-gene signature is closely associated with relapse-free and overall survival among patients with NSCLC. 我们的五个基因标记与非小细胞肺癌患者的无复发及总生存率密切相关。
- Nodal status correlates with disease-free and overall survival better than other prognostic factors. 与其他预后因素相比，结节状况与无病及总存活率关系更大。
- A bit of strategic cannibalism boosts overall survival chances for the larvae left "standing" when the music stops. 同类相食的策略让那些在“抢座位”游戏中幸存的幼虫拥有更高的生存几率。
- Clinical curing rate and the overall survival rate drop with the increasing of the shift rate of lymph nodes. 问题：临床治愈率和整体生存率随淋巴结转移率的增加而降低。
- Secondary endpoints for the study include disease-free survival, overall survival, safety, and tolerability. 该研究的次级目标包括无瘤生存率、总生存率、安全性以及耐受性。
- Primary and secondary endpoints were recurrence-free survival (RFS) and overall survival (OS), respectively. 最初的和辅助的的终点分别是无复发生存率和总生存率。
- In conclusion, the response rate and overall survival with docetaxel + cisplatin were greater than that seen with VC. 总之，缓解率及总生存在泰索帝+顺铂组比VC组好，在泰索帝+卡铂组与对照组相当。
- Overall survival after re-OLT was about 10% to 20% lower than that after primary OLT. 再次移植相对于首次移植生存率低大约10%25至20%25。
- The overall survival curves of the 2 cohorts were superimposable, the researchers commented. 研究者评论说，两组患者总的生存曲线重叠。
- Methods: End points were remission rates [overall response (OR) and complete response (CR)], failure-free survival (FFS), overall survival (OS)and toxicity. 方法临床观察的终点包括缓解率(总有效率OR和完全缓解率CR),无失败生存(FFS),总体生存(OS)及毒性。
- The premenopausal patients gave DFSR of 72.8% and 35.7% ( P <0.01), and their overall survival rates were 80.7% and 60.6% ( P < 0.05). 绝经前患者的内分泌治疗组和化疗组 5年无病生存率分别为 72 8%25和 35 7%25 (P <0 0 1) ;5年总生存率分别为 80 7%25和 6 0 0%25 (P <0 0 5 )。
- The total CR is 62.0% and disease-free survival (DFS) rate and overall survival (OS) rate at five-year are 52.3% and 46.8%,respectively. 全组患者治疗后的完全缓解(CR)率为62.;0%25，5年无病生存率和总生存率分别为52
